Skip to main content
SpringerLink
Log in

Induction Chemotherapy in Head and Neck Cancers

  • Chapter
  • First Online:
Induction Chemotherapy

  • 747 Accesses

Abstract

This chapter describes the rationale for induction chemotherapy in head and neck cancers, and offers a detailed account of the evolution of systemic and regional (intra-arterial) chemotherapy in this field. Emphasis is placed on representative trials but a range of successful experiences have indicated that there should be great potential for use of intra-arterial induction chemotherapy given not only as perfusion or chemoembolism, but also as method in parallel to radiotherapy, with the objective long-range cure or worthwhile palliation. According to most recent evidence, systemic induction chemotherapy has proven advantage in unresectable head and neck cancer and in case of larynx preservation, and intra-arterial chemotherapy has high merits in the treatment for regionally advanced and recurrent cancers and should be considered as preoperative induction treatment in management of resectable cancers of the oral cavity and anterior oropharynx.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. German Cancer Society, Head-Neck-Tumors, Treatment 2009 [Deutsche Krebsgesellschaft, Kopf-Hals-Tumoren, Therapie 2009]. (http://www.krebsgesellschaft.de/pat_ka_kopf_hals_tumor_therapie,108203.html).

  2. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck Cancer. Lancet. 2000;355:949–55.

    CAS  PubMed  Google Scholar 

  3. Taylor 4th SG, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol. 1994;12:385–95.

    PubMed  Google Scholar 

  4. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27:843–50.

    Article  PubMed  Google Scholar 

  5. Robbins KT. The evolving role of combined modality therapy in head and neck Cancer. Arch Otolaryngol Head Neck Surg. 2000;126:265–9.

    CAS  PubMed  Google Scholar 

  6. Domenge C, Hill C, Lefebvre JL, De Raucourt D, Rhein B, Wibault P, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d’Etude des Tumeurs de la Tête et du Cou (GETTEC). Br J Cancer. 2000;83:1594–8.

    Article  CAS  PubMed  Google Scholar 

  7. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer. 1995;71:83–91.

    Article  CAS  PubMed  Google Scholar 

  8. Pignon JP, le Maître A, Maillard E, Bourhis J, Collaborative Group MACH-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14.

    Article  PubMed  Google Scholar 

  9. Stell PM, Rawson NS. Adjuvant chemotherapy in head and neck cancer. Br J Cancer. 1990;61:779–87.

    Article  CAS  PubMed  Google Scholar 

  10. Volling P, Schröder M, Eckel H, Ebeling O, Stennert E. Primäre Chemotherapie bei Mundhöhlen- und Tonsillenkarzinomen. Ergebnisse einer prospektiv randomisierten Studie [Results of a prospective randomized trial with induction chemotherapy for cancer of the oral cavity and tonsils]. HNO. 1999;47:899–906.

    Article  CAS  PubMed  Google Scholar 

  11. Laccourreye O, Veivers D, Hans S, Ménard M, Brasnu D, Laccourreye H. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders. Cancer. 2001;92:1504–11.

    Article  CAS  PubMed  Google Scholar 

  12. Kovács AF, Grüterich G, Wagner M. Long-term complete remission of oral cancer after anti-neoplastic chemotherapy as single treatment modality: role of local chemotherapy. J Chemother. 2002;14:95–101.

    PubMed  Google Scholar 

  13. Weaver A, Fleming S, Vandenberg H, Drelichman A, Jacobs J, Kinzie J, et al. Cis-platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck. Head Neck Surg. 1982;4:370–3.

    Article  CAS  PubMed  Google Scholar 

  14. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst. 1993;85:95–111.

    Article  CAS  PubMed  Google Scholar 

  15. De Andres L, Brunet J, Lopez-Pousa A, Burgues J, Vega M, Tabernero JM, et al. Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer. J Clin Oncol. 1995;13:1493–500.

    PubMed  Google Scholar 

  16. Jacobs C, Lyman G, Velez-Garcia E, Sridhar KS, Knight W, Hochster H, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 1992;10:257–63.

    CAS  PubMed  Google Scholar 

  17. Paccagnella A, Orlando A, Marchiori C, Zorat PL, Cavaniglia G, Sileni VC, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst. 1994;86:265–72.

    Article  CAS  PubMed  Google Scholar 

  18. Thyss A, Schneider M, Santini J, Caldani C, Vallicioni J, Chauvel P, et al. Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. Br J Cancer. 1986;54:755–60.

    Article  CAS  PubMed  Google Scholar 

  19. Wang HM, Wang CH, Chen JS, Chang HK, Kiu MC, Liaw CC, et al. Cisplatin and 5-fluorouracil as neoadjuvant chemotherapy: predicting response in head and neck squamous cell ­cancer. J Formos Med Assoc. 1995;94:87–94.

    CAS  PubMed  Google Scholar 

  20. Clark JR, Busse PM, Norris Jr CM, Andersen JW, Dreyfuss AI, Rossi RM, et al. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results. J Clin Oncol. 1997;15:3100–10.

    CAS  PubMed  Google Scholar 

  21. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol. 1996;14:838–47.

    CAS  PubMed  Google Scholar 

  22. Posner MR, Colevas AD, Tishler RB. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck. Semin Oncol. 2000;27 Suppl 8:13–24.

    CAS  PubMed  Google Scholar 

  23. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.

    Article  Google Scholar 

  24. Calais G, Bardet E, Sire C, Alfonsi M, Bourhis J, Rhein B, et al. Radiotherapy with concomitant weekly docetaxel for stages III/IV oropharynx carcinoma. Results of the 98–02 GORTEC Phase II trial. Int J Radiat Oncol Biol Phys. 2004;58:161–6.

    Article  PubMed  Google Scholar 

  25. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent ­chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.

    Article  CAS  PubMed  Google Scholar 

  26. Bourhis J, Lapeyre M, Tortochaux J, Rives M, Aghili M, Bourdin S, et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol. 2006;24:2873–8.

    Article  PubMed  Google Scholar 

  27. Urba SG, Forastiere AA, Wolf GT, Esclamado RM, McLaughlin PW, Thornton AF. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol. 1994;12:946–53.

    CAS  PubMed  Google Scholar 

  28. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705–15.

    Article  CAS  PubMed  Google Scholar 

  29. Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW, et al. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol. 2009;20:921–7.

    Article  CAS  PubMed  Google Scholar 

  30. Ghi MG, Paccagnella A, D’Amanzo P, Mione CA, Fasan S, Paro S, et al. Neoadjuvant ­docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. Int J Radiat Oncol Biol Phys. 2004;59:481–7.

    Article  CAS  PubMed  Google Scholar 

  31. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695–704.

    Article  CAS  PubMed  Google Scholar 

  32. Kovács AF, Eberlein K, Hülsmann T. Organ preservation treatment using TPF-a pilot study in patients with advanced primary and recurrent cancer of the oral cavity and the maxillary sinus. Oral Maxillofac Surg. 2009;13:87–93.

    Article  PubMed  Google Scholar 

  33. Baghi M, Hambek M, Wagenblast J, May A, Gstoettner W, Knecht R. A phase II trial of ­docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN). Anticancer Res. 2006;26:585–90.

    CAS  PubMed  Google Scholar 

  34. Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, et al. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-­fluorouracil with a four-year follow-up. Oral Oncol. 2006;42:675–84.

    Article  CAS  PubMed  Google Scholar 

  35. Posner M, Vermorken JB. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer. Semin Oncol. 2008;35:221–8.

    Article  PubMed  Google Scholar 

  36. Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359:1116–27.

    Article  CAS  PubMed  Google Scholar 

  37. Klopp CT, Alford TC, Bateman J, Berry GN, Winship T. Fractionated intra-arterial cancer chemotherapy with methyl bis amine hydrochloride: a preliminary report. Ann Surg. 1950;132:811–32.

    Article  CAS  PubMed  Google Scholar 

  38. Sullivan RD, Jones R, Schnabel TG, Shorey J. The treatment of human cancer with intraarterial nitrogen mustard utilizing a simplified catheter technique. Cancer. 1953;6:121–4.

    Article  CAS  PubMed  Google Scholar 

  39. Kovács AF. Mundhöhlen- und Oropharynxkarzinome: neue Mittel und Wege der Therapie. Norderstedt: Books on demand; 2003.

    Google Scholar 

  40. Eckardt A, Kelber A. Palliative, intraarterial chemotherapy for advanced head and neck ­cancer using an implantable port system. J Oral Maxillofac Surg. 1994;52:1243–6.

    Article  CAS  PubMed  Google Scholar 

  41. Mees K, Lauterjung L, Kastenbauer E, Riederer A. Unsere Katheterführung zur intraarteriellen Chemotherapie bei Kopf- und Hals-Karzinomen [Personal catheter technic for intra-­arterial chemotherapy in cancers of the head and neck]. Laryngol Rhinol Otol (Stuttg). 1987;66:460–4.

    Article  CAS  Google Scholar 

  42. Bitter K. Erste Ergebnisse der zytostatischen Behandlung von Plattenepithelkarzinomen der Mundhöhle mit einer Kombination von Methotrexat und Bleomycin [Initial results of cytostatic therapy of squamous cell carcinoma of the oral cavity using a combination of methotrexate and bleomycin]. Dtsch Zahn Mund Kieferheilkd. 1973;60:81–93.

    CAS  Google Scholar 

  43. Bitter K. Pharmacokinetic behaviour of bleomycin-cobalt-57 with special regard to intraarterial perfusion of the maxillo-facial region. J Maxillofac Surg. 1976;4:226–31.

    Article  CAS  PubMed  Google Scholar 

  44. Eckardt A, editor. Intra-arterial chemotherapy in head and neck cancer – current results and future perspectives. Reinbek: Einhorn-Presse Verlag; 1999.

    Google Scholar 

  45. Harker GJS, Stephens FO. Comparison of intra-arterial versus intravenous 5-fluorouracil in sheep bearing epidermal squamous carcinoma. Eur J Cancer. 1992;28:1437–41.

    Article  Google Scholar 

  46. Harker GJS. Intra-arterial infusion chemotherapy in a sheep squamous cell carcinoma model. In: Eckardt A, editor. Intra-arterial chemotherapy in head and neck cancer – current results and future perspectives. Reinbek: Einhorn-Presse Verlag; 1999.

    Google Scholar 

  47. Eckman WW, Patlack CS, Fenstermacher JD. A critical evaluation of the principles governing the advantages of intra-arterial infusions. J Pharmacokinet Biopharm. 1974;2:257–85.

    Article  CAS  PubMed  Google Scholar 

  48. Campbell TN, Howell SB, Pfeifle CE, Wung WE, Bookstein J. Clinical pharmacokinetics of intraarterial cisplatin in humans. J Clin Oncol. 1983;1:755–62.

    CAS  PubMed  Google Scholar 

  49. Weiss M. Pharmacokinetic rationale for arterial drug infusion. In: Eckardt A, editor. Intra-arterial chemotherapy in head and neck cancer – current results and future perspectives. Reinbek: Einhorn-Presse Verlag; 1999.

    Google Scholar 

  50. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol. 1984;2:498–504.

    CAS  PubMed  Google Scholar 

  51. Abe R, Akiyoshi T, Koba F, Tsuji H, Baba T. ‘Two-route chemotherapy’ using intra-arterial cisplatin and intravenous sodium thiosulfate, its neutralizing agent, for hepatic malignancies. Eur J Cancer Clin Oncol. 1988;24:1671–4.

    Article  CAS  PubMed  Google Scholar 

  52. Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck. 1992;14:364–71.

    Article  CAS  PubMed  Google Scholar 

  53. Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol. 1994;12:2113–20.

    CAS  PubMed  Google Scholar 

  54. Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, et al. Characterization of a human squamous carcinoma cell line resistant to cisdiamminedichloroplatinum(II). Cancer Res. 1987;47:388–93.

    CAS  PubMed  Google Scholar 

  55. Los G, Blommaert FA, Barton R, Heath DD, den Engelse L, Hanchett C, et al. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation. Cancer Chemother Pharmacol. 1995;37:150–4.

    Article  CAS  PubMed  Google Scholar 

  56. Robbins KT, Storniolo AM, Hryniuk WM, Howell SB. “Decadose” effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studies. Laryngoscope. 1996;106:37–42.

    Article  CAS  PubMed  Google Scholar 

  57. Shea M, Koziol JA, Howell SB. Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther. 1984;35:419–25.

    Article  CAS  PubMed  Google Scholar 

  58. Goel R, Cleary SM, Horton C, Kirmani S, Abramson I, Kelly C, et al. Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. J Natl Cancer Inst. 1989;81:1552–60.

    Article  CAS  PubMed  Google Scholar 

  59. Pfeifle CE, Howell SB, Felthouse RD, Woliver TB, Andrews PA, Markman M, et al. High-dose cisplatin with sodium thiosulfate protection. J Clin Oncol. 1985;3:237–44.

    CAS  PubMed  Google Scholar 

  60. Muldoon LL, Pagel MA, Kroll RA, Brummett RE, Doolittle ND, Zuhowski EG, et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res. 2000;6:309–15.

    CAS  PubMed  Google Scholar 

  61. Kerber CW, Wong WH, Howell SB, Hanchett K, Robbins KT. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. AJNR Am J Neuroradiol. 1998;19:935–41.

    CAS  PubMed  Google Scholar 

  62. Kato T, Sato K, Sasaki R, Kakinuma H, Moriyama M. Targeted cancer chemotherapy with arterial microcapsule chemoembolization: review of 1013 patients. Cancer Chemother Pharmacol. 1996;37:289–96.

    Article  CAS  PubMed  Google Scholar 

  63. Araki T, Hihara T, Kachi K, Matsusako M, Ito M, Kohno K, et al. Newly developed transarterial chemoembolization material: CDDP-lipiodol suspension. Gastrointest Radiol. 1989;14:46–8.

    Article  CAS  PubMed  Google Scholar 

  64. Brassel F. Technical aspects of superselective chemotherapy in head and neck cancer. In: Eckardt A, editor. Intra-arterial chemotherapy in head and neck cancer – current results and future perspectives. Reinbek: Einhorn-Presse Verlag; 1999.

    Google Scholar 

  65. Okamoto Y, Konno A, Togawa K, Kato T, Amano Y. Microcapsule chemoembolization for head and neck cancer. Arch Otorhinolaryngol. 1985;242:105–11.

    Article  CAS  PubMed  Google Scholar 

  66. Okamoto Y, Konno A, Togawa K, Kato T, Tamakawa Y, Amano Y. Arterial chemoembolization with cisplatin microcapsules. Br J Cancer. 1986;53:369–75.

    Article  CAS  PubMed  Google Scholar 

  67. Gouyette A, Apchin A, Foka M, Richard JM. Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients. Eur J Cancer Clin Oncol. 1986;22:257–63.

    Article  CAS  PubMed  Google Scholar 

  68. Sileni VC, Fosser V, Maggian P, Padula E, Beltrame M, Nicolini M, et al. Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer. Cancer Chemother Pharmacol. 1992;30:221–5.

    Article  CAS  PubMed  Google Scholar 

  69. Jakowatz JG, Ginn GE, Snyder LM, Dieffenbach KW, Wile AG. Increased cisplatin tissue levels with prolonged arterial infusion in the rat. Cancer. 1991;67:2828–32.

    Article  CAS  PubMed  Google Scholar 

  70. Tohnai I, Fuwa N, Hayashi Y, Kaneko R, Tomaru Y, Hibino Y, et al. New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol. 1998;34:387–90.

    Article  CAS  PubMed  Google Scholar 

  71. Yoshimura H, Mishima K, Nariai Y, Sugihara M, Yoshimura Y. Targetting intraarterial infusion chemotherapy for oral cancers using Seldinger technique. In: Varma AK, Roodenburg JLN, editors. Oral oncology, volume VII. New Delhi: Macmillan India; 2001.

    Google Scholar 

  72. Tegeder I, Bräutigam L, Seegel M, Al-Dam A, Turowski B, Geisslinger G, et al. Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer. Clin Pharmacol Ther. 2003;73:417–26.

    Article  CAS  PubMed  Google Scholar 

  73. Iida E, Okada M, Mita T, Furukawa M, Ito K, Matsunaga N. Superselective intra-arterial chemotherapy for advanced maxillary sinus cancer: an evaluation of arterial perfusion with computed tomographic arteriography and of tumor response. J Comput Assist Tomogr. 2008;32:397–402.

    Article  PubMed  Google Scholar 

  74. Ishii A, Korogi Y, Nishimura R, Kawanaka K, Yamura M, Ikushima I, et al. Intraarterial infusion chemotherapy for head and neck cancers: evaluation of tumor perfusion with intraarterial CT during carotid arteriography. Radiat Med. 2004;22:254–9.

    PubMed  Google Scholar 

  75. Alexiou C, Jurgons R, Schmid RJ, Bergemann C, Henke J, Erhardt W, et al. Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target. 2003;11:139–49.

    Article  CAS  PubMed  Google Scholar 

  76. Alexiou C, Jurgons R, Seliger C, Brunke O, Iro H, Odenbach S. Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting. Anticancer Res. 2007;27:2019–22.

    CAS  PubMed  Google Scholar 

  77. Jaulerry C, Rodriguez J, Brunin F, Jouve M, Mosseri V, Point D, et al. Induction chemotherapy in advanced head and neck tumors: results of two randomised trials. Int J Radiat Oncol Biol Phys. 1992;23:483–9.

    Article  CAS  PubMed  Google Scholar 

  78. Forastiere AA, Baker SR, Wheeler R, Medvec BR. Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck. J Clin Oncol. 1987;5:1601–6.

    CAS  PubMed  Google Scholar 

  79. Kovács AF. Relevance of positive margins in case of adjuvant therapy of oral cancer. Int J Oral Maxillofac Surg. 2004;33:447–53.

    Article  PubMed  Google Scholar 

  80. Stephens FO. Intra-arterial chemotherapy in head and neck cancer. Historical perspectives – important developments, contributors and contributions. In: Eckardt A, editor. Intra-arterial chemotherapy in head and neck cancer – current results and future perspectives. Reinbek: Einhorn-Presse Verlag; 1999.

    Google Scholar 

  81. Ervin TJ, Clark JR, Weichselbaum RR, Fallon BG, Miller D, Fabian RL, et al. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol. 1987;5:10–20.

    CAS  PubMed  Google Scholar 

  82. Frei E, Clark JR, Fallon BG. Guidelines, regulations and clinical research. J Clin Oncol. 1986;4:1026–30.

    PubMed  Google Scholar 

  83. Volling P, Schröder M. Vorläufige Ergebnisse einer prospektiv randomisierten Studie zur primären Chemotherapie bei Mundhöhlen- und Pharynxkarzinomen [Preliminary results of a prospective randomized study of primary chemotherapy in carcinoma of the oral cavity and pharynx]. HNO. 1995;43:58–64.

    CAS  PubMed  Google Scholar 

  84. Baghi M, Mack MG, Hambek M, Bisdas S, Muerthel R, Wagenblast J, et al. Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy. Head Neck. 2007;29:104–8.

    Article  PubMed  Google Scholar 

  85. Kovács AF, Turowski B, Stefenelli U, Metzler D. Primary tumor volume as predicitive parameter for remission after intraarterial high-dose cisplatin in oral and oropharyngeal cancer: a mathematical model analysis. Chir Czaszkowo Szczęnkowo Twarzowa I Ortop Szczęnkowa Cranio Maxillofac Surg Orthodont. 2008;3:174–86.

    Google Scholar 

  86. Baker SR, Wheeler RH. Intraarterial chemotherapy for head and neck cancer: Part I. Theoretical considerations and drug delivery systems. Head Neck Surg. 1983;6:664–82.

    Article  CAS  PubMed  Google Scholar 

  87. Cruz Jr AB, McInnis WD, Aust JB. Triple drug intra-arterial infusion combined with x-ray therapy and surgery for head and neck cancer. Am J Surg. 1974;128:573–9.

    Article  PubMed  Google Scholar 

  88. Armstrong AL, Meeker WR. Palliation of inoperable head and neck cancer: combined intra-arterial infusion chemotherapy and irradiation. South Med J. 1978;71:1228–31.

    Article  CAS  PubMed  Google Scholar 

  89. Curioni C, Quadu G. Clinical trial of intra-arterial polychemotherapy in the treatment of carcinoma of the oral cavity. J Maxillofac Surg. 1978;6:207–16.

    Article  CAS  PubMed  Google Scholar 

  90. Szabó G, Kovács Á. Possibilities of enhancing the effectiveness of intra-arterial chemotherapy. Int J Oral Surg. 1980;9:33–44.

    Article  PubMed  Google Scholar 

  91. Koch U, Straehler-Pohl HJ, Helpap B, Frommhold H. Intraarterielle Chemotherapie bei Karzinomen der oberen Speisewege (Erfahrungsbericht über 128 Patienten) [Intraarterial chemotherapy in carcinomas of the oral cavity, oro- and hypopharynx]. Laryngol Rhinol Otol (Stuttg). 1981;60:71–6.

    Article  CAS  Google Scholar 

  92. Mika H. Die Remission ausgedehnter Karzinome der Mundhöhle und des Oropharynx unter intraarterieller Polychemotherapie mit Vincristin, Methotrexat, Bleomycin, Cisplatin (VMBP) [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)]. Laryngol Rhinol Otol (Stuttg). 1982;61:520–3.

    Article  CAS  Google Scholar 

  93. Arcangeli G, Nervi C, Righini R, Creton G, Mirri MA, Guerra A. Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol. 1983;1:101–7.

    Article  CAS  PubMed  Google Scholar 

  94. Molinari R, Jortay A, Sancho-Garnier H, Brugere J, Demard M, Desaulty A, et al. A randomized EORTC trial comparing intra-arterial infusion with methotrexate vs bleomycin as initial therapy in carcinoma of the oral cavity. Eur J Cancer Clin Oncol. 1982;18:807–12.

    Article  CAS  PubMed  Google Scholar 

  95. Galmarini FC, Yoel J, Nakasone J, Molina CM. Intraarterial association of cis-platinum and bleomycin in head and neck cancer. Auris Nasus Larynx. 1985;12 Suppl 2:S234–8.

    PubMed  Google Scholar 

  96. Milazzo J, Mohit-Tabatabai MA, Hill GJ, Raina S, Swaminathan A, Cheung NK, et al. Preoperative intra-arterial infusion chemotherapy for advanced squamous cell carcinoma of the mouth and oropharynx. Cancer. 1985;56:1014–7.

    Article  CAS  PubMed  Google Scholar 

  97. Inuyama Y, Fujii M, Tanaka J, Takaoka T, Hosoda H, Kohno N, et al. Combination chemotherapy with cisplatin and peplomycin in squamous cell carcinoma of the head and neck. Auris Nasus Larynx. 1986;13:191–8.

    Article  CAS  PubMed  Google Scholar 

  98. Mortimer JE, Taylor ME, Schulman S, Cummings C, Weymuller Jr E, Laramore G. Feasibility and efficacy of weekly intraarterial cisplatin in locally advanced (stage III and IV) head and neck cancers. J Clin Oncol. 1988;6:969–75.

    CAS  PubMed  Google Scholar 

  99. Cheung DK, Regan J, Savin M, Gibberman V, Woessner W. A pilot study of intraarterial chemotherapy with cisplatin in locally advanced head and neck cancers. Cancer. 1988;61:903–8.

    Article  CAS  PubMed  Google Scholar 

  100. Lee YY, Dimery IW, Van Tassel P, De Pena C, Blacklock JB, Goepfert H. Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors. Arch Otolaryngol Head Neck Surg. 1989;115:503–11.

    Article  CAS  PubMed  Google Scholar 

  101. Claudio F, Cacace F, Comella G, Coucourde F, Claudio L, Bevilacqua AM, et al. Intraarterial chemotherapy through carotid transposition in advanced head and neck cancer. Cancer. 1990;65:1465–71.

    Article  CAS  PubMed  Google Scholar 

  102. Frustaci S, Barzan L, Caruso G, Ghirardo R, Foladore S, Carbone A, et al. Induction intra-arterial cisplatin and bleomycin in head and neck cancer. Head Neck. 1991;13:291–7.

    Article  CAS  PubMed  Google Scholar 

  103. Richard JM, Kramar A, Molinari R, Lefèbvre JL, Blanchet F, Jortay A, et al. Randomised EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer. 1991;27:821–7.

    Article  CAS  PubMed  Google Scholar 

  104. Vieitez JM, Bilbao JI, Hidalgo OF, Martin S, Manzano RG, Tangco E. Intra-arterial chemotherapy with carboplatin and 5-fluorouracil in epidermoid cancer of the oropharynx and oral cavity. Reg Cancer Treat. 1991;4:152–5.

    Google Scholar 

  105. Hirai T, Korogi Y, Hamatake S, Nishimura R, Baba Y, Takahashi M, et al. Stages III and IV squamous cell carcinoma of the mouth: three-year experience with superselective intraarterial chemotherapy using cisplatin prior to definitive treatment. Cardiovasc Intervent Radiol. 1999;22:201–5.

    Article  CAS  PubMed  Google Scholar 

  106. Korogi Y, Hirai T, Nishimura R, Hamatake S, Sakamoto Y, Murakami R, et al. Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth: preliminary clinical experience. Am J Roentgenol. 1995;165:1269–72.

    CAS  Google Scholar 

  107. Scheel JV, Schilling V, Kastenbauer E, Knöbber D, Böhringer W. Cisplatin intraarteriell und sequentielle Bestrahlung. Langzeitergebnisse [Intra-arterial cisplatin and sequential radiotherapy. Long-term follow-up]. Laryngorhinootologie. 1996;75:38–42.

    Article  CAS  PubMed  Google Scholar 

  108. Siegel RS, Bank WO, Maung CC, Harisiadis L, Wilson WR. Assessment of efficacy and tolerance of high-dose intra-arterial cisplatin in advanced head and neck tumors. Proc Am Soc Clin Oncol (Abstract 1582); 1998.

    Google Scholar 

  109. Wilson WR, Siegel RS, Harisiadis LA, Davis DO, Nguyen HH, Bank WO. High-dose intraarterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2001;127:809–12.

    CAS  PubMed  Google Scholar 

  110. Kovács AF, Turowski B, Ghahremani TM, Loitz M. Intraarterial chemotherapy as neoadjuvant treatment of oral cancer. J Craniomaxillofac Surg. 1999;27:302–7.

    Article  PubMed  Google Scholar 

  111. Szabó G, Kreidler J, Hollmann K, Kovács Á, Németh G, Németh Z, et al. Intra-arterial preoperative cytostatic treatment versus preoperative irradiation: a prospective, randomized study of lingual and sublingual carcinomas. Cancer. 1999;86:1381–6.

    Article  PubMed  Google Scholar 

  112. Benazzo M, Caracciolo G, Zappoli F, Bernardo G, Mira E. Induction chemotherapy by superselective intra-arterial high-dose carboplatin infusion for head and neck cancer. Eur Arch Otorhinolaryngol. 2000;257:279–82.

    Article  CAS  PubMed  Google Scholar 

  113. Bertino G, Benazzo M, Gatti P, Bernardo G, Corbella F, Tinelli C, et al. Curative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: single-center five-year results. BMC Cancer. 2007;7:62.

    Article  PubMed  CAS  Google Scholar 

  114. Kovács AF. Chemoembolization using cisplatin crystals as neoadjuvant treatment of oral cancer. Cancer Biother Radiopharm. 2005;20:267–79.

    Article  PubMed  Google Scholar 

  115. Damascelli B, Patelli GL, Lanocita R, Di Tolla G, Frigerio LF, Marchianò A, et al. A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings. AJR Am J Roentgenol. 2003;181:253–60.

    PubMed  Google Scholar 

  116. Damascelli B, Patelli G, Tichá V, Di Tolla G, Frigerio LF, Garbagnati F, et al. Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx. J Vasc Interv Radiol. 2007;18:1395–403.

    Article  PubMed  Google Scholar 

  117. Molinari R, Chiesa F, Cantù G, Costa L, Grandi C, Sala L. Prognostic factors in cancer of the oral cavity and anterior oropharynx treated with preliminary neoadjuvant intra-arterial chemotherapy followed by surgery. In: Eckardt A, editor. Intra-arterial chemotherapy in head and neck cancer – current results and future perspectives. Reinbek: Einhorn-Presse Verlag; 1999.

    Google Scholar 

  118. Frustaci S, Barzan L, Comoretto R, Tumolo S, Lo Re G, Monfardini S. Local neurotoxicity after intra-arterial cisplatin in head and neck cancer. Cancer Treat Rep. 1987;71:257–9.

    CAS  PubMed  Google Scholar 

  119. Andersson T, Andreasson L, Björklund A, Brismar J, Elner A, Eneroth CM, et al. Intra-arterial chemotherapy of malignant head and neck tumours with superselective angiographic technique. Acta Otolaryngol Suppl. 1979;360:167–70.

    CAS  PubMed  Google Scholar 

  120. Kovács AF. Intraarterial chemotherapy and chemoembolization in head and neck cancer. Establishment as a neoadjuvant routine method. Cancer Ther. 2003;1:1–9.

    Google Scholar 

  121. Kovács AF. Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results. Br J Cancer. 2004;90:1323–8.

    Article  PubMed  CAS  Google Scholar 

  122. Kovács AF, Turowski B. Chemoembolization of oral and oropharyngeal cancer using a high-dose cisplatin crystal suspension and degradable starch microspheres. Oral Oncol. 2002;38:87–95.

    Article  PubMed  Google Scholar 

  123. Kovács AF, Obitz P, Wagner M. Monocomponent chemoembolization in oral and oropharyngeal cancer using an aqueous crystal suspension of cisplatin. Br J Cancer. 2002;86:196–202.

    Article  PubMed  Google Scholar 

  124. Kovács AF. Maximized combined modality treatment of an unselected population of oral and oropharyngeal cancer patients. Final results of a pilot study compared with a treatment-dependent prognosis index. J Craniomaxillofac Surg. 2006;34:74–84.

    Article  PubMed  Google Scholar 

  125. Kovács AF, Schiemann M, Turowski B. Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel – three year results of a pilot study. J Craniomaxillofac Surg. 2002;30:112–20.

    Article  PubMed  Google Scholar 

  126. Kovács AF, Mose S, Böttcher HD, Bitter K. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlenther Onkol. 2005;181:26–34.

    Article  PubMed  Google Scholar 

  127. Platz H, Fries R, Hudec M. Computer-aided individual prognoses of squamous cell carcinomas of the lips, oral cavity and oropharynx. Int J Oral Maxillofac Surg. 1992;21:150–5.

    Article  CAS  PubMed  Google Scholar 

  128. Kovács AF. Response to intraarterial induction chemotherapy: a prognostic parameter in oral and oropharyngeal cancer. Head Neck. 2006;28:678–88.

    Article  PubMed  Google Scholar 

  129. Kovács AF, Eberlein K, Smolarz A, Weidauer S, Rohde S. Organerhaltende Therapie bei inoperablen Patienten mit primären Mundhöhlen- und Oropharynxkarzinomen. Möglichkeiten und Grenzen [Organ-preserving treatment in inoperable patients with primary oral and oropharyngeal carcinoma: chances and limitations]. Mund Kiefer Gesichtschir. 2006;10:168–77.

    Article  PubMed  Google Scholar 

  130. Kishi K, Matsunaka M, Sato M, Sonomura T, Sakurane M, Uede K. T1 and T2 lip cancer: a superselective method of facial arterial infusion therapy – preliminary experience. Radiology. 1999;213:173–9.

    CAS  PubMed  Google Scholar 

  131. Nakasato T, Katoh K, Sone M, Ehara S, Tamakawa Y, Hoshi H, et al. Superselective continuous arterial infusion chemotherapy through the superficial temporal artery for oral cavity tumors. AJNR Am J Neuroradiol. 2000;21:1917–22.

    CAS  PubMed  Google Scholar 

  132. Wu CF, Chen CM, Chen CH, Shieh TY, Sheen MC. Continuous intraarterial infusion ­chemotherapy for early lip cancer. Oral Oncol. 2007;43:825–30.

    Article  CAS  PubMed  Google Scholar 

  133. Wu CF, Chen CM, Shen YS, Huang IY, Chen CH, Chen CY, et al. Effective eradication of oral verrucous carcinoma with continuous intraarterial infusion chemotherapy. Head Neck. 2008;30:611–7.

    Article  PubMed  Google Scholar 

  134. Fuwa N, Kodaira T, Furutani K, Tachibana H, Nakamura T, Nakahara R, et al. Intra-arterial chemoradiotherapy for locally advanced oral cavity cancer: analysis of therapeutic results in 134 cases. Br J Cancer. 2008;98:1039–45.

    Article  CAS  PubMed  Google Scholar 

  135. Tomura N, Kobayashi M, Hirano J, Watarai J, Okamoto Y, Togawa K, et al. Chemoembolization of head and neck cancer with carboplatine microcapsules. Acta Radiol. 1996;37:52–6.

    CAS  PubMed  Google Scholar 

  136. Tomura N, Kato K, Hirano H, Hirano Y, Watarai J. Chemoembolization of maxillary tumors via the superficial temporal artery using a coaxial catheter system. Radiat Med. 1998;16:157–60.

    CAS  PubMed  Google Scholar 

  137. Li H, Wang C, Wen Y, Wu H. Treatment of squamous cell carcinoma of the tongue using arterial embolism with cisplatin-loaded albumin microspheres: a microstructural and ultrastructural investigation. Chin J Dent Res. 1999;2:61–6.

    CAS  PubMed  Google Scholar 

  138. Suvorova IuV, Tarazov PG, Korytova LI, Sokurenko VP, Khazova TV. Arterial chemoembolization in the combined treatment of malignant tumors of the tongue and maxilla: preliminary results. Vestn Rentgenol Radiol. 2002;2:23–8.

    PubMed  Google Scholar 

  139. Li WZ, Ma ZB, Zhao T. Transcatheter arterial chemoembolization of oral squamous-cell carcinoma: a clinicopathological observation. Di Yi Jun Yi Da Xue Xue Bao. 2004;24:614–8.

    PubMed  Google Scholar 

  140. He H, Huang J, Ping F, Chen G, Zhang S, Dong Y. Anatomical and clinical study of lingual arterial chemoembolization for tongue carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:e1–5.

    PubMed  Google Scholar 

  141. Sokurenko VP, Korytova LI, Tarazov PG, Suvorova IuV. Intra-arterial chemotherapy and chemoembolization in the combined treatment for locally advanced carcinoma of the head and neck. Vopr Onkol. 2008;54:625–30.

    CAS  PubMed  Google Scholar 

  142. Konno A, Ishikawa K, Terada N, Numata T, Nagata H, Okamoto Y. Analysis of long-term results of our combination therapy for squamous cell cancer of the maxillary sinus. Acta Otolaryngol Suppl. 1998;537:57–66.

    CAS  PubMed  Google Scholar 

  143. Song M, Chen FJ, Zeng ZY, Wu GH, Wei MW, Guo ZM, et al. Clinical value of inducing chemotherapy for patients with advanced tongue cancer. Ai Zheng. 2002;21:68–70.

    PubMed  Google Scholar 

  144. He H, Ping F, Chen G, Zhang S. Chemoembolization of tongue carcinoma with ethylcellulose microcapsuled carboplatinum and its basic study. Artif Cells Blood Substit Immobil Biotechnol. 2008;36:114–22.

    Article  CAS  PubMed  Google Scholar 

  145. Milburn GHW, Truter MR. The crystal structures of cis- and trans-dichlorodiammineplatinum (II). Inorg Phys Theor J Chem Soc (A). 1966;11:1609–16.

    Article  Google Scholar 

  146. Medac, editor. Professional information Medac Cisplatin Medac [in German]. Hamburg: Medac; 2000.

    Google Scholar 

  147. McEvoy GK, editor. American hospital formulary service drug information 91. Bethesda: American Society of Hospital Pharmacists; 1991.

    Google Scholar 

  148. Greene RF, Chatterji DC, Hiranaka PK, Gallelli JF. Stability of cisplatin in aqueous solution. Am J Hosp Pharm. 1979;36:38–43.

    CAS  PubMed  Google Scholar 

  149. Kristjansson F, Sternson LA, Lindenbaum S. An investigation on possible oligomer formation in pharmaceutical formulations of cisplatin. Int J Pharm. 1988;41:67–74.

    Article  CAS  Google Scholar 

  150. Bastian P, Kissel T, Bartkowski R. Maligne Lebererkrankungen: Arterielle Chemo- und Embolisationstherapie mit Hilfe von Trägersystemen. PZ Prisma. 1999;6:235–48.

    Google Scholar 

  151. Damascelli B, Cantù G, Mattavelli F, Tamplenizza P, Bidoli P, Leo E, et al. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): Phase II study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity. Cancer. 2001;92:2592–602.

    Article  CAS  PubMed  Google Scholar 

  152. van Es RJ, Nijsen JF, Dullens HF, Kicken M, van der Bilt A, Hennink W, et al. Tumour embolization of the Vx2 rabbit head and neck cancer model with Dextran hydrogel and Holmium-poly(L-lactic acid) microspheres: a radionuclide and histological pilot study. J Craniomaxillofac Surg. 2001;29:289–97.

    Article  PubMed  Google Scholar 

  153. Szepesi T, Stadler B, Hohenberg G, Hollmann K, Kühböck J, Mailath G. Prognostische Faktoren bei der Behandlung inoperabler orofazialer Malignome mit simultaner Radio- und Chemotherapie [Prognostic factors in the treatment of inoperable orofacial tumors with simultaneous radiotherapy and intra-arterial chemotherapy]. Strahlentherapie. 1985;161:299–307.

    CAS  PubMed  Google Scholar 

  154. Scholz F, Scholz R, Schratter A, Hollmann K. Intraarterielle Chemotherapie bei Tumoren im maxillo-facialen Bereich. In: Vinzenz K, Waclawiczek HW, editors. Chirurgische Therapie von Kopf-Hals-Karzinomen. New York: Springer; 1992.

    Google Scholar 

  155. Imai S, Kajihara Y, Munemori O, Kamei T, Mori T, Handa T, et al. Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers. Eur J Radiol. 1995;21:94–9.

    Article  CAS  PubMed  Google Scholar 

  156. Robbins KT, Kumar P, Regine WF, Wong FS, Weir 3rd AB, Flick P, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. 1997;38:263–71.

    Article  CAS  PubMed  Google Scholar 

  157. Oya R, Ikemura K. Targeted intra-arterial carboplatin infusion with concurrent radiotherapy and administration of tegafur for advanced squamous cell carcinoma of the oral cavity and oropharynx. In: Eckardt A, editor. Intra-arterial chemotherapy in head and neck cancer – current results and future perspectives. Reinbek: Einhorn-Presse Verlag; 1999.

    Google Scholar 

  158. Fuwa N, Ito Y, Matsumoto A, Kamata M, Kodaira T, Furutani K, et al. A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study. Cancer. 2000;89:2099–105.

    Article  CAS  PubMed  Google Scholar 

  159. Robbins KT, Kumar P, Wong FS, Hartsell WF, Flick P, Palmer R, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000;22:687–93.

    Article  CAS  PubMed  Google Scholar 

  160. Regine WF, Valentino J, Arnold SM, Haydon RC, Sloan D, Kenady D, et al. High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 2001;19:3333–9.

    CAS  PubMed  Google Scholar 

  161. Balm AJ, Rasch CR, Schornagel JH, Hilgers FJ, Keus RB, Schultze-Kool L, et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 2004;26:485–93.

    Article  PubMed  Google Scholar 

  162. Homma A, Furuta Y, Suzuki F, Oridate N, Hatakeyama H, Nahahashi T, et al. Rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer. Head Neck. 2005;27:65–71.

    Article  PubMed  Google Scholar 

  163. Robbins KT, Kumar P, Harris J, McCulloch T, Cmelak A, Sofferman R, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol. 2005;23:1447–54.

    Article  CAS  PubMed  Google Scholar 

  164. Spring PM, Valentino J, Arnold SM, Sloan D, Kenady D, Kudrimoti M, et al. Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. Cancer. 2005;104:1765–71.

    Article  CAS  PubMed  Google Scholar 

  165. Robbins KT, Vicario D, Seagren S, Weisman R, Pellitteri P, Kerber C, et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg. 1994;168:419–22.

    Article  CAS  PubMed  Google Scholar 

  166. Rasch CRN, Hauptmann M, Schornagel J, Wijers O, Buter J, Gregor T, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase III trial. Cancer. 2010;116:2159–65.

    Article  CAS  PubMed  Google Scholar 

  167. Ackerstaff AH, Balm AJ, Rasch CR, de Boer JP, Wiggenraad R, Rietveld DH, et al. First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck. 2009;31:77–84.

    Article  PubMed  Google Scholar 

  168. Endo S, Suzuki S, Tsuji K, Niwa H, Noguchi Y, Yoshida K, et al. Intraarterial concomitant chemoradiation for tongue cancer: analysis of 20 patients. Nippon Jibiinkoka Gakkai Kaiho. 2005;108:689–93.

    Article  PubMed  Google Scholar 

  169. Iguchi H, Kusuki M, Nakamura A, Nishiura H, Kanazawa A, Takayama M, et al. Concurrent chemoradiotherapy with pirarubicin and 5-fluorouracil for resectable oral and maxillary carcinoma. Acta Otolaryngol Suppl. 2004;554:55–61.

    CAS  PubMed  Google Scholar 

  170. Iguchi H, Kusuki M, Nakamura A, Kanazawa A, Hachiya K, Yamane H. Outcome of preoperative concurrent chemoradiotherapy and surgery for resectable lingual squamous cell ­carcinoma greater than 3 cm: the possibility of less extensive surgery. Oral Oncol. 2006;42:391–7.

    Article  CAS  PubMed  Google Scholar 

  171. Ishii A, Korogi Y, Hirai T, Nishimura R, Murakami R, Ikushima I, et al. Intraarterial infusion chemotherapy and conformal radiotherapy for cancer of the mouth: prediction of the histological response to therapy with magnetic resonance imaging. Acta Radiol. 2007;48:900–6.

    Article  CAS  PubMed  Google Scholar 

  172. Ito K, Shiba H, Fujiwara K, Kunimoto Y, Tanimoto S, Higami Y, et al. Superselective intraarterial chemotherapy using low dose CBDCA and Pirarubicin with concurrent radiotherapy for head and neck cancer. Nippon Jibiinkoka Gakkai Kaiho. 2005;108:195–201.

    Article  PubMed  Google Scholar 

  173. Yamashita Y, Goto M, Katsuki T. Chemotherapy by superselective intraarterial infusion of nedaplatin combined with radiotherapy for oral cancer. Gan To Kagaku Ryoho. 2002;29:905–9.

    PubMed  Google Scholar 

  174. Yamashita Y, Shikimori M, Goto M. Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer. Gan To Kagaku Ryoho. 2005;32:1267–71.

    Google Scholar 

  175. Homma A, Oridate N, Suzuki F, Taki S, Asano T, Yoshida D, et al. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer. 2009;115:4705–14.

    Article  CAS  PubMed  Google Scholar 

  176. Ikushima I, Korogi Y, Ishii A, Hirai T, Yamura M, Nishimura R, et al. Superselective intra-arterial infusion chemotherapy for stage III/IV squamous cell carcinomas of the oral cavity: midterm results. Eur J Radiol. 2008;66:7–12.

    Article  CAS  PubMed  Google Scholar 

  177. Rohde S, Kovács AF, Turowski B, Yan B, Zanella F, Berkefeld J. Intra-arterial high-dose chemotherapy with cisplatin as part of a palliative treatment concept in oral cancer. AJNR Am J Neuroradiol. 2005;26:1804–9.

    CAS  PubMed  Google Scholar 

  178. Donegan WL, Harris P. Regional chemotherapy with combined drugs in cancer of the head and neck. Cancer. 1976;38:1479–83.

    Article  CAS  PubMed  Google Scholar 

  179. Eckardt A, Kelber A, Pytlik C. Palliative intra-arterial (i.a.) chemotherapy with carboplatin (CBDCA) and 5-FU in unresectable advanced (stage III and IV) head and neck cancer using implantable port-systems. Eur J Surg Oncol. 1995;21:486–9.

    Article  CAS  PubMed  Google Scholar 

  180. Huntington MC, DuPriest RW, Fletcher WS. Intra-arterial bleomycin therapy in inoperable squamous cell carcinomas. Cancer. 1973;31:153–8.

    Article  CAS  PubMed  Google Scholar 

  181. Matras H, Bürkle K, Watzek G, Kühböck J, Pötzi P, Dimopoulos J. Concept of cytostatic therapy in advanced tumours of the head and neck. J Maxillofac Surg. 1979;7:150–4.

    Article  CAS  PubMed  Google Scholar 

  182. Teymoortash A, Bien S, Dalchow C, Sesterhenn A, Lippert BM, Werner JA. Selective high-dose intra-arterial cisplatin as palliative treatment for incurable head and neck cancer. Onkologie. 2004;27:547–51.

    Article  CAS  PubMed  Google Scholar 

  183. Yokoyama J. Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer. Gan To Kagaku Ryoho. 2002;29:169–75.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Private practice, Waldstraße 61a, D - 64569, Nauheim, Germany

    Adorján F. Kovács

Authors
  1. Adorján F. Kovács
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adorján F. Kovács .

Editor information

Editors and Affiliations

  1. Abt. Onkologische Chirurgie, Medias Klinikum GmbH & Co. KG, Krankenhausstr. 1, Burghausen, 84489, Germany

    Karl Reinhard Aigner

  2. Inkerman Street 16, Mosman, 2088, New South Wales, Australia

    Frederick O. Stephens

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kovács, A.F. (2011). Induction Chemotherapy in Head and Neck Cancers. In: Aigner, K., Stephens, F. (eds) Induction Chemotherapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18173-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18173-3_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-18172-6

  • Online ISBN: 978-3-642-18173-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation